| NAME |
ERTUGLIFLOZIN 5MG/SITAGLIPTIN 100MG TAB,ORAL |
| VA GENERIC NAME |
ERTUGLIFLOZIN/SITAGLIPTIN |
| DOSAGE FORM |
TAB,ORAL |
| FDA MED GUIDE |
Ertugliflozin-Sitagliptin_(Steglujan)_(Oct_2022).pdf |
| ACTIVE INGREDIENTS |
|
| CS FEDERAL SCHEDULE |
Unscheduled |
| SINGLE/MULTI SOURCE PRODUCT |
Multisource |
| NATIONAL FORMULARY NAME |
ERTUGLIFLOZIN/SITAGLIPTIN TAB,ORAL |
| CREATE DEFAULT POSSIBLE DOSAGE |
NO |
| POSSIBLE DOSAGES TO CREATE |
1x Possible Dosage |
| PACKAGE |
Both Inpatient and Outpatient |
| CODING SYSTEM |
|
| COPAY TIER |
-
- COPAY TIER LEVEL: 3
- COPAY EFFECTIVE DATE: 2018-03-01 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
ERTUGLIFLOZIN 5MG/SITAGLIPTIN 100MG TAB |
| VA PRODUCT IDENTIFIER |
E0732 |
| TRANSMIT TO CMOP |
YES |
| VA DISPENSE UNIT |
TAB |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4037270 |
| EFFECTIVE DATE/TIME |
-
- 2018-02-05 00:00:00
- STATUS: ACTIVE
|
